Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PUR.WAR
- Price
- 10.57
- Stock movement down
- -0.11 (-1.03%)
- Company name
- Pure Biologics Spólka Akcyjna
- Exchange
- (WAR ,
- Currency
- PLN )
- Sector
- Healthcare >Biotechnology
- Market cap
- 37.39M
- Ent value
- 54.83M
- Price/Sales
- 541.93
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 78.74%
- 1 year return
- 32.13%
- 3 year return
- -43.43%
- 5 year return
- -23.75%
- 10 year return
- -
Last updated: 2025-04-15
DIVIDENDS
PUR.WAR does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 541.93 |
| Price to Book | - |
| EV to Sales | 794.65 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 3.54M |
| EPS (TTM) | -10.10 |
| FCF per share (TTM) | -4.84 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 69.00K |
| Gross profit (TTM) | -1.68M |
| Operating income (TTM) | -28.08M |
| Net income (TTM) | -33.62M |
| EPS (TTM) | -10.10 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -2439.13% |
| Operating margin (TTM) | -40697.10% |
| Profit margin (TTM) | -48724.64% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 5.29M |
| Net receivables | 345.00K |
| Total current assets | 18.69M |
| Goodwill | 0.00 |
| Intangible assets | 222.00K |
| Property, plant and equipment | 736.00K |
| Total assets | 19.65M |
| Accounts payable | 2.77M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 9.58M |
| Total liabilities | 22.73M |
| Shareholder's equity | -3.08M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -15.94M |
| Capital expenditures (TTM) | 153.00K |
| Free cash flow (TTM) | -16.09M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -171.09% |
| Return on Invested Capital | -338.23% |
| Cash Return on Invested Capital | -161.92% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 10.68 |
| Daily high | 10.68 |
| Daily low | 10.25 |
| Daily Volume | 28K |
| All-time high | 142.00 |
| 1y analyst estimate | - |
| Beta | 1.41 |
| EPS (TTM) | -10.10 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PUR.WAR | S&P500 | |
| Current price drop from All-time high | -92.56% | -12.04% |
| Highest price drop | -96.20% | -56.47% |
| Date of highest drop | 21 Dec 2023 | 9 Mar 2009 |
| Avg drop from high | -54.25% | -11.07% |
| Avg time to new high | 33 days | 12 days |
| Max time to new high | 1064 days | 1805 days |
COMPANY DETAILS
Marketcap
37.39M
Marketcap category
Small-cap
Description
Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurological autoimmune disorders, including neuromyelitis optica and myasthenia gravis; and provides contract research for pharmaceutical and biotechnology companies. Pure Biologics S.A. was incorporated in 2010 and is headquartered in Wroclaw, Poland.
Employees
4
Website
Investor relations
-
SEC filings
CEO
Country
Poland
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found